Tuesday, June 7, 2022

FDA advisers back Novavax COVID-19 shots as new U.S. optionFDA advisers back Novavax COVID-19 shots as new U.S. optionFDA advisers back Novavax COVID-19 shots as new U.S. option

FDA advisers back Novavax COVID-19 shots as new U.S. option

FDA's vaccine chief Dr. Peter Marks said another choice in the U.S. may entice at least some vaccine holdouts -- whatever their reason -- to consider rolling up their sleeves.



from Section Page News - Modern Healthcare https://ift.tt/zZLJlm4

No comments:

Post a Comment